4.6 Article

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy

Torsten Hoffmann et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)

Article Geriatrics & Gerontology

EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects

Alida A. Gouw et al.

NEUROBIOLOGY OF AGING (2017)

Article Clinical Neurology

Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease

Shorena Janelidze et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)

Article Clinical Neurology

Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease

Maike Hartlage-Ruebsamen et al.

ACTA NEUROPATHOLOGICA (2015)

Review Clinical Neurology

Neuroinflammation in Alzheimer's disease

Michael T. Heneka et al.

LANCET NEUROLOGY (2015)

Article Clinical Neurology

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease

Konstantin Hellwig et al.

ALZHEIMERS RESEARCH & THERAPY (2015)

Review Psychology, Biological

The trees and the forest: Characterization of complex brain networks with minimum spanning trees

C. J. Stam et al.

INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2014)

Article Chemistry, Physical

Pyroglutamylated Amyloid-β Peptide Reverses Cross β-Sheets by a Prion-Like Mechanism

Jason O. Matos et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2014)

Article Chemistry, Physical

Activity and Architecture of Pyroglutamate-Modified Amyloid-β (AβpE3-42) Pores

Alan L. Gillman et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2014)

Article Clinical Neurology

Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis

George S. Bloom

JAMA NEUROLOGY (2014)

Article Multidisciplinary Sciences

Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β

Justin M. Nussbaum et al.

NATURE (2012)

Article Geriatrics & Gerontology

Young Alzheimer patients show distinct regional changes of oscillatory brain dynamics

Hanneke de Waal et al.

NEUROBIOLOGY OF AGING (2012)

Article Neurosciences

Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease

Lars M. Ittner et al.

NATURE REVIEWS NEUROSCIENCE (2011)

Review Clinical Neurology

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Clifford R. Jack et al.

LANCET NEUROLOGY (2010)

Review Neurosciences

Nonlinear multivariate analysis of neurophysiological signals

E Pereda et al.

PROGRESS IN NEUROBIOLOGY (2005)

Review Clinical Neurology

EEG dynamics in patients with Alzheimer's disease

JS Jeong

CLINICAL NEUROPHYSIOLOGY (2004)

Article Clinical Neurology

EEG coherence in Alzheimer's dementia

G Adler et al.

JOURNAL OF NEURAL TRANSMISSION (2003)

Article Multidisciplinary Sciences

Alzheimer's disease is a synaptic failure

DJ Selkoe

SCIENCE (2002)

Article Neurosciences

Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy

G Rodriguez et al.

NEUROPSYCHOBIOLOGY (2002)